Previous close | 6.07 |
Open | 6.06 |
Bid | 5.97 x 0 |
Ask | 6.01 x 0 |
Day's range | 5.99 - 6.07 |
52-week range | 4.35 - 6.22 |
Volume | |
Avg. volume | 70,014 |
Market cap | 608.256M |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Knight Therapeutics ( TSE:GUD ) First Quarter 2024 Results Key Financial Results Revenue: CA$86.6m (up 4.9% from 1Q...
For many, the main point of investing is to generate higher returns than the overall market. But even the best stock...
Last week saw the newest full-year earnings release from Knight Therapeutics Inc. ( TSE:GUD ), an important milestone...